← back to search

Kim Theilgaard‐Mönch

University of Copenhagen · DK
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Protein Tyrosine Phosphatases, Synthesis and biological activity, and RNA Interference and Gene Delivery.
h-index
31
citations
6,006
works
120
NIH funding
primary concept
Biology
email

Recent publications

The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
Leukemia 2023cited by 24position: middledoi
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
Blood 2022cited by 123position: middledoi
Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
Cancer Research 2022cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Julian Walfridsson · Karolinska Institutet1 papers (2023–2023)Kristian Reckzeh · Lund University1 papers (2022–2022) · 1 papers (2023–2023) · 1 papers (2023–2023)Frederik Otzen Bagger · Glostrup Hospital1 papers (2023–2023) · 1 papers (2023–2023)Lars Juhl Jensen · University of Copenhagen1 papers (2022–2022)Kirsten Grønbæk · University of Copenhagen1 papers (2023–2023) · 1 papers (2023–2023)Kristian Helin · Institute of Cancer Research1 papers (2023–2023) · 1 papers (2022–2022) · 1 papers (2023–2023)Ilaria Piga · University of Padua1 papers (2022–2022)Ying Ge · Medical College of Wisconsin1 papers (2023–2023)Vidyasiri Vemulapalli · University of Houston1 papers (2022–2022)Marie Locard‐Paulet · University of Manchester1 papers (2022–2022) · 1 papers (2023–2023)Bo Porse · University of Copenhagen1 papers (2023–2023) · 1 papers (2022–2022) · 1 papers (2023–2023)